Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Goodwill & Intangibles (2023 - 2025)

Jin Medical International (ZJYL) has disclosed Goodwill & Intangibles for 3 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • Quarterly Goodwill & Intangibles fell 3.84% to $1.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Sep 2025, down 3.84% year-over-year, with the annual reading at $1.1 million for FY2025, 3.84% down from the prior year.
  • Goodwill & Intangibles hit $1.1 million in Q3 2025 for Jin Medical International, down from $1.1 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $1.1 million in Q3 2024 to a low of $154364.0 in Q3 2023.
  • Historically, Goodwill & Intangibles has averaged $801331.3 across 3 years, with a median of $1.1 million in 2025.
  • Biggest five-year swings in Goodwill & Intangibles: soared 642.94% in 2024 and later dropped 3.84% in 2025.
  • Year by year, Goodwill & Intangibles stood at $154364.0 in 2023, then skyrocketed by 642.94% to $1.1 million in 2024, then decreased by 3.84% to $1.1 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for ZJYL at $1.1 million in Q3 2025, $1.1 million in Q3 2024, and $154364.0 in Q3 2023.